Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02288611
Other study ID # AJWA STUDY
Secondary ID
Status Completed
Phase N/A
First received November 3, 2014
Last updated November 6, 2014
Start date May 2012
Est. completion date September 2014

Study information

Verified date November 2014
Source University of Reading
Contact n/a
Is FDA regulated No
Health authority Saudi Arabia: Ministry for Higher Education
Study type Interventional

Clinical Trial Summary

This aim of this study is to investigate the prebiotic potential of date fruits in healthy human volunteers compared to a control diet. Each arm was 21 days in duration, separated by a 14 days washout period. Faecal samples, and blood samples will be collected from each volunteer and high resolution analytical techniques (HPLC, LC-MS and NMR) will be employed to characterise the whole system metabolic response to ingestion of date fruits compared to the control. Changes in microbial parameters and metabolite profiles will be correlated with changes in biomarkers of chronic disease, including faecal water genotoxicity, cellular reactions, blood lipids and bowel movements.


Description:

This aim of this study is to investigate the prebiotic potential of date fruit consumption in healthy human volunteers compared to a diet which does not contain dates; control (maltodextrin-dextrose, 40.2g) or intervention treatment 7 date fruits (50g) to 22 healthy human volunteers. Each arm was 21 days in duration, separated by a 14 days washout period. Thus, we will also address fundamental questions about the relationship between fermentation of non digestible carbohydrates, the gut microbiota and the changes in faecal short chain fatty acids (SCFA profiles), ammonia and bile acids. To this end faecal samples, and blood samples will be collected from each volunteer and high resolution analytical techniques (High Performance Liquid Chromatography; Liquid Chromatography-Mass Spectrometry and Nuclear Magnetic Resonance) will be employed to characterise the whole system metabolic response to ingestion of date fruits compared to the control. Changes in microbial parameters and metabolite profiles will be correlated with changes in biomarkers of chronic disease, including faecal water genotoxicity, cellular reactions, blood lipids and bowel movements.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date September 2014
Est. primary completion date September 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A to 55 Years
Eligibility Inclusion Criteria:

- Signed consent form

- Body mass index - 18.5 - 30 inclusive

- Age 18 - 55 years

- Good general health as determined by medical questionnaires Requirements for diet and medication during study

- No intake of additional supplementary prebiotics (i.e. such as fructo-oligosaccharides) - please note that consumption of foods that are naturally prebiotic, e.g. cereal grains and leeks, may be consumed as normal

- No intake of probiotics (i.e. live yoghurts), drugs active on gastrointestinal motility, antibiotic treatment or any class of laxative

- All concomitant medication must be recorded in diaries and case record forms

- Usual diet, fluid intake and exercise levels should be maintained during trial period

- Please inform the investigator if you consume antibiotics during the trial. You will not be able to continue, as this may affect your faecal bacteria.

Exclusion Criteria:

- Requirements to take long-term medication active on the gastro-intestinal tract

- Use of antibiotics within the previous 6 months

- Anaemia

- Diabetes mellitus

- History of alcohol or drug abuse

- Current smoker

- Intake of any experimental drug within 4 weeks of the start of the study

- Excessive alcohol consumption (more than 21 units/wk male, 14 units/wk female)

- Females who are breast-feeding, may be pregnant, or if of child-bearing potential and are not using effective contraceptive precautions

- Major surgery, which might limit participation in, or completion of, the study.

- Participation in a study involving prebiotics or probiotics within the previous 3 months

- Physical or mental diseases that are likely to limit participation or completion of the study

- Severe allergy to foods or severe abnormal drug reactions

- Chronic gastroenterological complaints

- Intake of other supplementary prebiotics or probiotics, drugs active on gastrointestinal motility, or a laxative of any class during or within the four weeks prior to the start of the study

- Aged below 18 or over 55 years

- Have a BMI of less than 18.5 or more than 30

- Gluten allergy

- Calorie restriction or other special diet (e.g. Atkins diet, montignac diet) 6 weeks prior to the start of the study

- Vaccination against with the current season's influenza and AH1N1 flu

- Manifestation of allergy, asthma and dermatitis

Study Design

Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Date fruit - Ajwa variety
Twenty-two healthy human individuals were randomly assigned to consume 7 date fruits (approx. 50g). Each arm was 21 days in duration, separated by a 14 days washout period.
Maltodextrin/Dextrose
Twenty-two healthy human individuals were randomly assigned to consume Maltodextrin/dextrose , 40.2g. Each arm was 21 days in duration, separated by a 14 days washout period.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Reading

References & Publications (1)

Eid NM, Al-Awadi B, Vauzour D, Oruna-Concha MJ, Spencer JP. Effect of cultivar type and ripening on the polyphenol content of date palm fruit. J Agric Food Chem. 2013 Mar 13;61(10):2453-60. doi: 10.1021/jf303951e. Epub 2013 Feb 26. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in large intestinal microbiota composition verses control intervention (0-3 months) Microbial profile assessed by FISH 3 months No
Secondary Change from baseline in Bowel function verses the control intervention (0-3 months 3 months No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT03457454 - Reducing Rural Colon Cancer Disparities
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Completed NCT03390907 - Hybrid APC Assisted EMR for Large Colon Polyps N/A
Recruiting NCT03175224 - APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors Phase 2
Completed NCT04079478 - The AID Study: Artificial Intelligence for Colorectal Adenoma Detection
Active, not recruiting NCT04057274 - Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth N/A
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Not yet recruiting NCT05147545 - Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects N/A
Recruiting NCT05026268 - The Laparoscopic Right Colectomy With Intracoroporeal Anastomosis N/A
Not yet recruiting NCT03277235 - Effect of a Resilience Model-Based Care Plan in Newly Diagnosed Colorectal Cancer Patients N/A
Active, not recruiting NCT02959541 - PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer N/A
Active, not recruiting NCT02730702 - Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A
Recruiting NCT02577627 - Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC N/A
Terminated NCT02628535 - Safety Study of MGD009 in B7-H3-expressing Tumors Phase 1
Recruiting NCT02526836 - Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer Phase 2/Phase 3